Multidrug-resistant tuberculosis

CHA

Tag: Multidrug-resistant tuberculosis

Tuberculosis: Clinical trial results offer hope to DR-TB patients with short, effective treatment

LONDON – TB-PRACTECAL, a clinical trial led by Doctors Without Borders/Médecins Sans Frontières (MSF), has found that a new, all-oral, six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculosis (RR-TB) [1] than the currently accepted standard of care....

Read more

Tuberculosis: EndTB clinical trial for multidrug-resistant TB completes enrolment

BOSTON/PARIS — Hundreds of patient volunteers from four continents have enrolled in a trial that aims to find safer, shorter, and effective treatments for multidrug-resistant tuberculosis (MDR-TB), an airborne, infectious disease that has grown resistant to standard medications. A group of scientists and...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons